Literature DB >> 10858314

p50(cdc37) is a nonexclusive Hsp90 cohort which participates intimately in Hsp90-mediated folding of immature kinase molecules.

S D Hartson1, A D Irwin, J Shao, B T Scroggins, L Volk, W Huang, R L Matts.   

Abstract

Hsp90 and p50(cdc37) provide a poorly understood biochemical function essential to certain protein kinases, and recent models describe p50(cdc37) as an exclusive hsp90 cohort which links hsp90 machinery to client kinases. We describe here the recovery of p50(cdc37) in immunoadsorptions directed against the hsp90 cohorts FKBP52, cyp40, p60HOP, hsp70, and p23. Additionally, monoclonal antibodies against FKBP52 coadsorb maturation intermediates of the hsp90-dependent kinases p56(lck) and HRI, and the presence of these maturation intermediates significantly increases the representation of p50(cdc37) and hsp90 on FKPB52 machinery. Although the native heterocomplex between hsp90 and p50(cdc37) is salt-labile, their dynamic interactions with kinase substrates produce kinase-chaperone heterocomplexes which are highly salt-resistant. The hsp90 inhibitor geldanamycin does not directly disrupt the native association of hsp90 with p50(cdc37) per se, but does result in the formation of salt-labile hsp90-kinase heterocomplexes which lack the p50(cdc37) cohort. We conclude that p50(cdc37) does not simply serve as a passive structural bridge between hsp90 and its kinase substrates; instead, p50(cdc37) is a nonexclusive hsp90 cohort which responds to hsp90's nucleotide-regulated conformational switching during the generation of high-affinity interactions within the hsp90-kinase-p50(cdc37) heterocomplex.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10858314     DOI: 10.1021/bi000315r

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  25 in total

1.  Alternative approaches to Hsp90 modulation for the treatment of cancer.

Authors:  Jessica A Hall; Leah K Forsberg; Brian S J Blagg
Journal:  Future Med Chem       Date:  2014-09       Impact factor: 3.808

Review 2.  Cdc37 goes beyond Hsp90 and kinases.

Authors:  Morag MacLean; Didier Picard
Journal:  Cell Stress Chaperones       Date:  2003       Impact factor: 3.667

3.  HSP90 interacts with RAR1 and SGT1 and is essential for RPS2-mediated disease resistance in Arabidopsis.

Authors:  Akira Takahashi; Catarina Casais; Kazuya Ichimura; Ken Shirasu
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-22       Impact factor: 11.205

4.  CK2 controls multiple protein kinases by phosphorylating a kinase-targeting molecular chaperone, Cdc37.

Authors:  Yoshihiko Miyata; Eisuke Nishida
Journal:  Mol Cell Biol       Date:  2004-05       Impact factor: 4.272

5.  Cdc37p is required for stress-induced high-osmolarity glycerol and protein kinase C mitogen-activated protein kinase pathway functionality by interaction with Hog1p and Slt2p (Mpk1p).

Authors:  Patricija Hawle; Danielle Horst; Jan Paul Bebelman; Xiao Xian Yang; Marco Siderius; Saskia M van der Vies
Journal:  Eukaryot Cell       Date:  2007-01-12

6.  Charged linker sequence modulates eukaryotic heat shock protein 90 (Hsp90) chaperone activity.

Authors:  Shinji Tsutsumi; Mehdi Mollapour; Chrisostomos Prodromou; Chung-Tien Lee; Barry Panaretou; Soichiro Yoshida; Matthias P Mayer; Leonard M Neckers
Journal:  Proc Natl Acad Sci U S A       Date:  2012-02-06       Impact factor: 11.205

7.  Inhibition of gastric tumor growth by a novel Hsp90 inhibitor.

Authors:  Chunwan Lu; Di Liu; Jing Jin; Hemantkumar Deokar; Yi Zhang; John K Buolamwini; Xiaoming Yu; Chunhong Yan; Xiaoguang Chen
Journal:  Biochem Pharmacol       Date:  2013-02-13       Impact factor: 5.858

8.  Hsp90-Cdc37 chaperone complex regulates Ulk1- and Atg13-mediated mitophagy.

Authors:  Joung Hyuck Joo; Frank C Dorsey; Aashish Joshi; Kristin M Hennessy-Walters; Kristie L Rose; Kelly McCastlain; Ji Zhang; Rekha Iyengar; Chang Hwa Jung; Der-Fen Suen; Meredith A Steeves; Chia-Ying Yang; Stephanie M Prater; Do-Hyung Kim; Craig B Thompson; Richard J Youle; Paul A Ney; John L Cleveland; Mondira Kundu
Journal:  Mol Cell       Date:  2011-08-19       Impact factor: 17.970

9.  Hsp90 charged-linker truncation reverses the functional consequences of weakened hydrophobic contacts in the N domain.

Authors:  Shinji Tsutsumi; Mehdi Mollapour; Christian Graf; Chung-Tien Lee; Bradley T Scroggins; Wanping Xu; Lenka Haslerova; Martin Hessling; Anna A Konstantinova; Jane B Trepel; Barry Panaretou; Johannes Buchner; Matthias P Mayer; Chrisostomos Prodromou; Len Neckers
Journal:  Nat Struct Mol Biol       Date:  2009-10-18       Impact factor: 15.369

Review 10.  Alternate strategies of Hsp90 modulation for the treatment of cancer and other diseases.

Authors:  Gary E L Brandt; Brian S J Blagg
Journal:  Curr Top Med Chem       Date:  2009       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.